Canopy Health Innovations Provides Operational Update: Provisional Patents and Additional Funding Secured
October 26, 2026
Canopy Growth Announces Results of 2026 Annual General and Special Meeting of Shareholders
Canopy Growth Announces Results of 2026 Annual General and Special Meeting of Shareholders
October 22, 2026
Canopy Growth to Report Second Quarter Fiscal 2027 Financial Results on November 6, 2026
Canopy Growth to Report Second Quarter Fiscal 2027 Financial Results on November 6, 2026
October 13, 2026
Canopy Growth’s Smiths Falls Facility Becomes Canada’s Only EU GMP-certified Site Combining Softgel Manufacturing with Primary Packaging of Softgels, Oral Liquids and Dried Cannabis Flower
Canopy Growth Corporation (“Canopy Growth”, “our”, “we” or the “Company”) (TSX: WEED) (Nasdaq: CGC), a leading global company committed to bettering lives through cannabis, today announced that its Smiths Falls, Ontario facility (“Smiths Falls”) has received European Union Good Manufacturing Practice (“EU GMP”) certification for manufacturing and packaging activities from the Tübingen Regional Council (Regierungspräsidium Tübingen), Baden-Württemberg’s competent medicines regulatory authority in Germany.
September 28, 2026
Canopy Growth Appoints Sebastian Blöte as Country Manager for Germany
Canopy Growth Appoints Sebastian Blöte as Country Manager for Germany
September 25, 2026
Canopy Growth Announces Adjournment of 2026 Annual General and Special Meeting Due to Lack of Quorum
Canopy Growth Announces Adjournment of 2026 Annual General and Special Meeting Due to Lack of Quorum
September 22, 2026
Canopy Growth Expands European Medical Cannabis Supply into the UK
Canopy Growth Expands European Medical Cannabis Supply into the UK
